CoChat
Sign Up
Cited by 54

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Analysis of RNA from Alzheimer’s Disease Post-mortem Brain Tissues

Clement, Christian, Hill, James M., Dua, Prerna, Culicchia, Frank, Lukiw, Walter J.·2016·Molecular Neurobiology
DOI 10.1007/s12035-015-9105-6PMC PMC5450164
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12035-015-9105-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 40

  1. Duff K (2002) Neuropsychopharmacology: the fifth generation of progress. Lippincott, Williams, & Wilkins, Philadelphia, Pennsylvania; edited by KL Davis, D Charney, JT Coyle, and C Nemeroff. Am Coll Neuropsychol-Pharmacol
  2. Foley AM, Ammar ZM, Lee RH, Mitchell CS (2014) Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer’s disease. J Alzheimers Dis 2014 Oct 31. [Epub ahead of print] PubMed PMID: 25362040.
  3. Franco R, Cedazo-Minguez A (2014) Successful therapies for Alzheimer’s disease: why so many in animal models and none in humans? Front Pharmacol 5:146. doi: 10.3389/fphar.2014.00146 · DOI · Paper page
  4. Watts JC, Prusiner SB (2014) Mouse models for studying the formation and propagation of prions. J Biol Chem 289:19841–19849. doi: 10.1074/jbc.R114.550707 · DOI
  5. Pluta R, Jabłoński M, Ułamek-Kozioł M, Kocki J, Brzozowska J, Januszewski S, Furmaga-Jabłońska W, Bogucka-Kocka A, Maciejewski R, Czuczwar SJ (2013) Sporadic Alzheimer’s disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer’s disease genes. Mol Neurobiol 48:500–515. doi: 10.1007/s12035-013-8439-1 · DOI
  6. Pluta R, Furmaga-Jabłońska W, Maciejewski R, Ułamek-Kozioł M, Jabłoński M (2013) Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer’s disease. Mol Neurobiol 47:425–434. doi: 10.1007/s12035-012-8360-z · DOI
  7. Hossain MS, Gilbert P (2010) Concepts of death: a key to our adjustment. Illness, Crisis and Loss, Vol 18. No 1 · DOI
  8. Preece P, Cairns NJ (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118:60–71 · DOI
  9. Lukiw WJ, LeBlanc HJ, Carver LA, McLachlan DR, Bazan NG (1998) Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease. J Mol Neurosci 11:67–78 · DOI
  10. Cui JG, Zhao Y, Lukiw WJ (2005) Isolation of high spectral quality RNA using run-on gene transcription; application to gene expression profiling of human brain. Cell Mol Neurobiol 25:789–794 · DOI
  11. Bhattacharjee S, Lukiw WJ (2013) Alzheimer’s disease and the microbiome. Front Cell Neurosci 7:153. doi: 10.3389/fncel.2013.00153 · DOI
  12. Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao Y, Lukiw WJ (2014) Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Front Aging Neurosci 6:127. doi: 10.3389/fnagi.2014.00127 · DOI
  13. Can I, Javan GT, Pozhitkov AE, Noble PA (2014) Distinctive thanatomicrobiome signatures found in the blood and internal organs of humans. J Microbiol Methods 106:1–7. doi: 10.1016/j.mimet.2014.07.026 · DOI
  14. Lukiw WJ, Alexandrov PN (2012) Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer’s disease (AD) brain. Mol Neurobiol 46:11–19 · DOI · Paper page
  15. Rajagopalan LE, Malter JS (1997) Regulation of eukaryotic messenger RNA turnover. Prog Nucleic Acid Res Mol Biol 56:257–286 · DOI
  16. Sethi P, Lukiw WJ (2009) Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex. Neurosci Lett 459:100–104. doi: 10.1016/j.neulet.2009.04.052 · DOI · Paper page
  17. Pogue AI, Hill JM, Lukiw WJ (2014) MicroRNA (miRNA): sequence and stability, viroid-like properties, and disease association in the CNS. Brain Res 1584:73–79. doi: 10.1016/j.brainres.2014.03.042 · DOI
  18. Donaldson AE, Lamont IL (2013) Biochemistry changes that occur after death: potential markers for determining post-mortem interval. PLoS One 8(11):e82011. doi: 10.1371/journal.pone.0082011 · DOI
  19. Lukiw WJ (2013) Variability in microRNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer’s disease (AD). Front Cell Neurosci 7:133. doi: 10.3389/fncel.2013.00133 · DOI
  20. Lukiw WJ, Handley P, Wong L, McLachlan DRC (1992) BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochem Res 17:591–597 · DOI
  21. Zhao Y, He S, Liu C, Ru S, Zhao H, Yang Z et al (2008) MicroRNA regulation of messenger-like noncoding RNAs: a network of mutual microRNA control. Trends Genet 24:323–327. doi: 10.1016/j.tig.2008.04.004 · DOI
  22. Li J, Liu Y, Kim T, Min R, Zhang Z (2010) Gene expression variability within and between human populations and implications toward disease susceptibility. PLoS Comput Biol 6:e1000910. doi: 10.1371/journal. pcbi.1000910 · DOI
  23. Raj A, Rifkin SA, Andersen E, van Oudenaarden A (2010) Variability in gene expression underlies incomplete penetrance. Nature 463:913–918 · DOI
  24. Hulse AM, Cai JJ (2013) Genetic variants contribute to gene expression variability. Genetics 193:95–108 · DOI
  25. Zhao Y, Bhattacharjee S, Jones BM, Dua P, Alexandrov PN, Hill JM et al (2013) Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a. Neuroreport 24:318–323. doi: 10.1097/WNR.0b013e32835fb6b0 · DOI
  26. von Roretz C, Di Marco S, Mazroui R, Gallouzi IE (2011) Turnover of AU-rich-containing mRNAs during stress: a matter of survival. Wiley Interdiscip Rev RNA 2:336–347. doi: 10.1002/wrna.55 · DOI
  27. Higaki S, Gebhardt B, Lukiw WJ, Thompson H, Hill J (2003) Gene expression profiling in the HSV-1 latently infected mouse trigeminal ganglia following hyperthermic stress. Curr Eye Res 26:231–238 · DOI
  28. García-Martínez J, Aranda A, Pérez-Ortín JE (2004) Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol Cell 15:303–313 · DOI
  29. Aitman TJ (2001) DNA microarrays in medical practice. BMJ 323:611–615 · DOI
  30. Bier FF, von Nickisch-Rosenegk M, Ehrentreich-Förster E, Reiss E, Henkel J, Strehlow R, Andresen D (2008) DNA microarrays. Adv Biochem Eng Biotechnol 109:433–453
  31. Watts JC, Condello C, Stöhr J, Oehler A, Lee J, DeArmond SJ et al (2014) Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients. Proc Natl Acad Sci U S A 111:10323–10328. doi: 10.1073/pnas.1408900111 · DOI
  32. Chitravas N, Jung RS, Kofskey DM, Blevins JE, Gambetti P, Leigh RJ, et al Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol 70:437-444. doi: 10.1002/ana.22454 · DOI
  33. Carninci P (2014) Genomics: mice in the ENCODE spotlight. Nature 515:346–347. doi: 10.1038/515346a · DOI
  34. Olson MV (2012) Human genetic individuality. Annu Rev Genomics Hum Genet 13:1–27. doi: 10.1146/annurev-genom-090711-163825 · DOI
  35. Gerstenecker A, Mast B (2014) Mild cognitive impairment: a history and the state of current diagnostic criteria. Int Psychogeriatr 5:1–13
  36. Tsolaki M (2014) Clinical workout for the early detection of cognitive decline and dementia. Eur J Clin Nutr 68:1186–1191. doi: 10.1038/ejcn.2014.189 · DOI
  37. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269. doi: 10.1016/j.jalz.2011.03.005. Pu · DOI · Paper page
  38. Thompson PM, Vinters HV (2012) Pathologic lesions in neurodegenerative diseases. Prog Mol Biol Transl Sci 107:1–40. doi: 10.1016/B978-0-12-385883-2.00009-6 · DOI
  39. Zetterberg H, Lautner R, Skillbäck T, Rosén C, Shahim P, Mattsson N, Blennow K (2014) CSF in Alzheimer’s disease. Adv Clin Chem 65:143–172 · DOI
  40. Bolognani F, Perrone-Bizzozero NI (2008) RNA-protein interactions and control of mRNA stability in neurons. J Neurosci Res 86:481–489 · DOI

Cited by

Sorted by citations

See all 54

Metadata

Authors
Clement, C., Hill, J. M., Dua, P., Culicchia, F., & Lukiw, W. J.
Venue
Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Published
2015-01-29
Volume
53
Issue
2
Pages
1322-1328
ISSN
  • 0893-7648
  • 1559-1182
DOI
10.1007/s12035-015-9105-6
PMC
PMC5450164
Cited by
54
References
3
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review